Antiviral effect, safety, and pharmacokinetics of five-day oral administration of Deleobuvir (BI 207127), an investigational hepatitis C virus RNA polymerase inhibitor, in patients with chronic hepatitis C
在慢性丙型肝炎患者中，研究性丙型肝炎病毒RNA聚合酶抑制剂Deleobuvir（BI 207127）口服给药五天的抗病毒效果、安全性和药代动力学。
期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.00565-13
Larrey, Dominique; Lohse, Ansgar W; Trepo, Christian; Bronowicki, Jean-Pierre; Arastéh, Keikawus; Bourlière, Marc; Calleja, Jose Luis; Stern, Jerry O; Nehmiz, Gerhard; Abdallah, Nasri; Berger, Kristi L; Marquis, Martin; Steffgen, Jürgen; Kukolj, George
